AzTrials
AzTrials

HealthyPhase 1NCT04705532

Behavioral and Neurophysiological Effects of Multichannel Executive Network tDCS Combined With Preferred Music Stimulation

A Phase 1 study testing tDCS, Music and White noise in people with Healthy, run by University of Liege at 1 site in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims at comparing the effects of transcranial direct current stimulation combined with music on neurophysiological outcomes in healthy participants. This study also aims to evaluate the effects of tDCS combined with music on cognition. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
tDCS, Music and White noise
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
24 participants
Where
1 siteBelgium
Study dates
4 Oct 2019to 30 Dec 2021
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • healthy adults

Who cannot join

  • neurological disorders
  • psychiatric disorders
  • contra-indication to tDCS (eg, metallic brain implant, pacemaker)
  • pregnancy
  • alcool abuse
  • active smoker

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • University Hospital of Liege

    Liège, 4000

Other trials in Belgium

About this study

This study aims at comparing the effects of transcranial direct current stimulation combined with music on neurophysiological outcomes in healthy participants. This study also aims to evaluate the effects of tDCS combined with music on cognition.

Conditions
Healthy
Being tested
tDCS, Sham tDCS, Music, White noise

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • tDCSDevice

    Multi-channel tDCS will be applied over the executive network for 20 minutes at 4mA

  • Sham tDCSDevice

    Sham tDCS will consist of applying the same parameters as for active but the corresponding device will be turned off after 30 seconds as to simulate the initial sensation of the active current. A current of 2mA will still be used (but turned off after 30 sec). The electrodes that will be used will be the same as for the active tDCS condition and the electrodes placement as well.

  • MusicOther

    Subjects will listen to their preferred music for 20 minutes

  • White noiseOther

    Subjects will listen to a white noise for 20 minutes

Study groups in NCT04705532
Study groupRoleWhat they receive
tDCS/musicExperimentalactive tDCS combined with music
Receives: Device: tDCS; Other: Music
sham tDCS/musicExperimentalSham tDCS combined with music
Receives: Device: Sham tDCS; Other: Music
tDCS/white noiseExperimentalactive tDCS combined with white noise
Receives: Device: tDCS; Other: White noise
sham tDCS/white noiseExperimentalsham tDCS combined with white noise
Receives: Device: Sham tDCS; Other: White noise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 3-back

    The subject is presented with a sequence of stimuli, and the task consists of indicating when the current stimulus matches the one from 3 steps earlier in the sequence.

    Measured: It will be measured over the course of four weeks

Secondary outcomes (3)
  1. Stroop

    The subject has to name the font color of a printed word, while it can have a mismatch between the word and the color (ex: green is written in red).

    Measured: It will be measured over the course of four weeks

  2. EEG - alpha power

    Brain activity will be measured with an electroencephalography collected at rest. We will first look at the change in alpha power (8-12Hz)

    Measured: It will be measured over the course of four weeks

  3. EEG - beta power

    Brain activity will be measured with an electroencephalography collected at rest. We will also look at the change in other frequency bands (e.g., beta, theta, delta).

    Measured: It will be measured over the course of four weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jan 2021
  2. Study start4 Oct 2019
  3. Primary completion30 Dec 2021
  4. Study completion30 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04705532
Sponsor's protocol ID
2014-280
Status last verified
Aug 2024
First submitted
7 Jan 2021
Last updated
5 Aug 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing tDCS, Music and White noise in people with Healthy, run by University of Liege at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

3-back (time frame: It will be measured over the course of four weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in